TELO

SEC source: 0001493152-26-025115 · ownership.xml · derivative · entry 2

Whalen Matthew Pratt · CIK 0002033867 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2034-08-27

F2 · price: The reporting person agreed to cancellation of the option granted to him on 08/27/2024, in exchange for a new option having a lower exercise price.

SEC source: 0001493152-26-025115 · ownership.xml · derivative · entry 1

Whalen Matthew Pratt · CIK 0002033867 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2036-05-21

F2 · price: The reporting person agreed to cancellation of the option granted to him on 08/27/2024, in exchange for a new option having a lower exercise price.

F1 · derivative.exercise_date: The options are fully exercisable.

F2 · balance_after: The reporting person agreed to cancellation of the option granted to him on 08/27/2024, in exchange for a new option having a lower exercise price.

SEC source: 0001493152-26-025113 · ownership.xml · derivative · entry 2

Del Giudice Matthew Paul · CIK 0002016630 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2034-08-27

F2 · price: The reporting person agreed to cancellation of the option granted to him on 08/27/2024, in exchange for a new option having a lower exercise price.

SEC source: 0001493152-26-025113 · ownership.xml · derivative · entry 1

Del Giudice Matthew Paul · CIK 0002016630 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2036-05-21

F2 · price: The reporting person agreed to cancellation of the option granted to him on 08/27/2024, in exchange for a new option having a lower exercise price.

F1 · derivative.exercise_date: The options are fully exercisable.

F2 · balance_after: The reporting person agreed to cancellation of the option granted to him on 08/27/2024, in exchange for a new option having a lower exercise price.

SEC source: 0001493152-26-025114 · ownership.xml · derivative · entry 2

MacPherson Edward Clouston · CIK 0002015989 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2034-08-27

F2 · price: The reporting person agreed to cancellation of the option granted to him on 08/27/2024, in exchange for a new option having a lower exercise price.

SEC source: 0001493152-26-025114 · ownership.xml · derivative · entry 1

MacPherson Edward Clouston · CIK 0002015989 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2036-05-21

F2 · price: The reporting person agreed to cancellation of the option granted to him on 08/27/2024, in exchange for a new option having a lower exercise price.

F1 · derivative.exercise_date: The options are fully exercisable.

F2 · balance_after: The reporting person agreed to cancellation of the option granted to him on 08/27/2024, in exchange for a new option having a lower exercise price.

SEC source: 0001493152-26-025116 · ownership.xml · derivative · entry 5

Aminov Erez · CIK 0001986112 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000,000 shares

Expires 2035-05-27

F2 · price: The reporting person agreed to cancellation of options granted to him on 08/27/2024 and 05/27/2025, in exchange for new options having a lower exercise price.

SEC source: 0001493152-26-025116 · ownership.xml · derivative · entry 4

Aminov Erez · CIK 0001986112 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000,000

Underlying: Common Stock · 2,000,000 shares

Expires 2036-05-21

F2 · price: The reporting person agreed to cancellation of options granted to him on 08/27/2024 and 05/27/2025, in exchange for new options having a lower exercise price.

F1 · derivative.exercise_date: The options are fully exercisable.

F2 · balance_after: The reporting person agreed to cancellation of options granted to him on 08/27/2024 and 05/27/2025, in exchange for new options having a lower exercise price.

SEC source: 0001493152-26-025116 · ownership.xml · derivative · entry 3

Aminov Erez · CIK 0001986112 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,960,170 shares

Expires 2034-08-27

F2 · price: The reporting person agreed to cancellation of options granted to him on 08/27/2024 and 05/27/2025, in exchange for new options having a lower exercise price.

SEC source: 0001493152-26-025116 · ownership.xml · derivative · entry 2

Aminov Erez · CIK 0001986112 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,960,170

Underlying: Common Stock · 1,960,170 shares

Expires 2036-05-21

F2 · price: The reporting person agreed to cancellation of options granted to him on 08/27/2024 and 05/27/2025, in exchange for new options having a lower exercise price.

F1 · derivative.exercise_date: The options are fully exercisable.

F2 · balance_after: The reporting person agreed to cancellation of options granted to him on 08/27/2024 and 05/27/2025, in exchange for new options having a lower exercise price.

SEC source: 0001493152-26-018911 · ownership.xml · nonDerivative · entry 1

Aminov Erez · CIK 0001986112 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,319,710

F1 · security: The shares of common stock, no par value of the Issuer issued to the Reporting Person are in exchange for the Reporting Person's shares of TELI Pharmaceuticals, Inc. ("TELI") in connection with the Issuer's acquisition of TELI.

F1 · kind: The shares of common stock, no par value of the Issuer issued to the Reporting Person are in exchange for the Reporting Person's shares of TELI Pharmaceuticals, Inc. ("TELI") in connection with the Issuer's acquisition of TELI.

F1 · price: The shares of common stock, no par value of the Issuer issued to the Reporting Person are in exchange for the Reporting Person's shares of TELI Pharmaceuticals, Inc. ("TELI") in connection with the Issuer's acquisition of TELI.

SEC source: 0001493152-26-034813 · ownership.xml · derivative · entry 1

Whalen Matthew Pratt · CIK 0002033867 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-04-16

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on April 16, 2026.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on April 16, 2026, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). All of the options vested immediately upon issuance.

F2 · balance_after: The stock options were issued to the Reporting Person on April 16, 2026, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). All of the options vested immediately upon issuance.

SEC source: 0001493152-26-034812 · ownership.xml · derivative · entry 1

Del Giudice Matthew Paul · CIK 0002016630 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-04-16

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on April 16, 2026.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on April 16, 2026, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). All of the options vested immediately upon issuance.

F2 · balance_after: The stock options were issued to the Reporting Person on April 16, 2026, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). All of the options vested immediately upon issuance.

SEC source: 0001493152-26-034811 · ownership.xml · derivative · entry 1

MacPherson Edward Clouston · CIK 0002015989 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-04-16

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on April 16, 2026.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on April 16, 2026, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). All of the options vested immediately upon issuance.

F2 · balance_after: The stock options were issued to the Reporting Person on April 16, 2026, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). All of the options vested immediately upon issuance.

SEC source: 0001641172-25-013148 · ownership.xml · derivative · entry 2

Aminov Erez · CIK 0001986112 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of Issuer's common stock.

F4 · derivative.exercise_date: The RSUs were issued to the Reporting Person on May 28, 2025, pursuant to a grant under the Plan. The RSUs are fully vested as of the date of grant.

F5 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of Issuer's common stock.

SEC source: 0001641172-25-013148 · ownership.xml · derivative · entry 1

Aminov Erez · CIK 0001986112 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000,000

Underlying: Common Stock · 2,000,000 shares

Expires 2035-05-28

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on May 27, 2025.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on May 28, 2025, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). The stock options are fully vested as of the date of grant.

SEC source: 0001493152-24-047638 · ownership.xml · derivative · entry 1

Bay Shore Trust · CIK 0001986593 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 2,339,025

Underlying: Common Stock · 100,000 shares

Expires 2028-06-15

F2 · price: Bona Fide Gift. No compensation was given to the donor for the gifting of securities.

F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Brian McNulty ("Mr. McNulty") as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001493152-24-034367 · ownership.xml · derivative · entry 1

Whalen Matthew Pratt · CIK 0002033867 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-08-27

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 26, 2024.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025.

F2 · balance_after: The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025.

SEC source: 0001493152-24-034369 · ownership.xml · derivative · entry 1

Del Giudice Matthew Paul · CIK 0002016630 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-08-27

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 26, 2024.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025.

F2 · balance_after: The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025.

SEC source: 0001493152-24-034372 · ownership.xml · derivative · entry 1

MacPherson Edward Clouston · CIK 0002015989 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-08-27

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 26, 2024.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025.

F2 · balance_after: The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025.

SEC source: 0001493152-24-034373 · ownership.xml · derivative · entry 1

Jerman Michael Allen · CIK 0001979732 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-08-27

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 26, 2024.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025.

F2 · balance_after: The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025.

SEC source: 0001493152-24-034370 · ownership.xml · derivative · entry 1

Aminov Erez · CIK 0001986112 · Director · CEO & Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,960,170

Underlying: Common Stock · 1,960,170 shares

Expires 2034-08-27

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 26, 2024.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025.

F2 · balance_after: The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025.

SEC source: 0001493152-24-034962 · ownership.xml · derivative · entry 1

Yanez Michelle · CIK 0001958023 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2034-08-27

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 26, 2024.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50,000 stock options of such grant shall vest, respectively, on each of February 26, 2025, August 26, 2025, February 26, 2026 and August 26, 2026.

F2 · balance_after: The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50,000 stock options of such grant shall vest, respectively, on each of February 26, 2025, August 26, 2025, February 26, 2026 and August 26, 2026.

SEC source: 0001493152-25-004853 · ownership.xml · nonDerivative · entry 2

Aminov Erez · CIK 0001986112 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,600

F1 · kind: Represents the sale of common stock that should have been reported on Form 4.

SEC source: 0001493152-25-004853 · ownership.xml · nonDerivative · entry 1

Aminov Erez · CIK 0001986112 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,600

F1 · kind: Represents the sale of common stock that should have been reported on Form 4.

SEC source: 0000897069-24-000395 · form4.xml · nonDerivative · entry 3

Bay Shore Trust · CIK 0001986593 · 10% owner

McNulty Brian Patrick · CIK 0001996353 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 1,902,659

F3 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities.

SEC source: 0000897069-24-000395 · form4.xml · nonDerivative · entry 2

Bay Shore Trust · CIK 0001986593 · 10% owner

McNulty Brian Patrick · CIK 0001996353 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 1,365,646

F2 · ownership.nature: These securities are owned directly by the MIRALOGX, LLC, of which the Trust holds all of the membership interests, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0000897069-24-000395 · form4.xml · nonDerivative · entry 1

Bay Shore Trust · CIK 0001986593 · 10% owner

McNulty Brian Patrick · CIK 0001996353 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 5,455,431

F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Brian McNulty ("Mr. McNulty") as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.